14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for CRBP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 39.99 4.69 %
R2 39.41 3.17 %
R1 39.05 2.23 %
Current price: 38.20
Support S1 37.89 -0.82 %
S2 37.53 -1.76 %
S3 36.94 -3.29 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 44.93 17.62 %
R2 40.32 5.55 %
R1 39.24 2.72 %
Current price 38.20
Support S1 37.74 -1.20%
S2 34.60 -9.42%
S3 30.90 -19.11%

CRBP Predictions History

6 years ago
JS predicted that CRBP for 2017-09-01 is going $7.63 (-0.26%)

6 years ago
Edward.Wu.11201 predicted that CRBP for 2017-09-01 is going $6.65 (-14.19%)

Rank:

6 years ago
JuanC Villegas predicted that CRBP for 2017-06-07 is going $6.86 (3.16%)

6 years ago
bbullish2 predicted that CRBP for 2017-06-07 is going $6.68 (0.45%)

6 years ago
Jon predicted that CRBP for 2017-06-07 is going $6.07 (-8.72%)

6 years ago
Raul predicted that CRBP for 2017-06-06 is going $6.85 (-2.84%)

Rank:

7 years ago
JS predicted that CRBP for 2017-05-02 is going $7.09 (2.75%)

7 years ago
JuanC Villegas predicted that CRBP for 2017-05-02 is going $7.06 (-1.26%)

7 years ago
JS predicted that CRBP for 2017-05-01 is going $7.35 (2.08%)

7 years ago
JuanC Villegas predicted that CRBP for 2017-05-01 is going $7.21 (0.14%)

Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT